Skip to main content Help with accessibility Skip to main navigation

February 2022 updates to the website

The website has now been updated following February's LSCMMG

The following guidelines have been added/updated:

Overactive bladder in female adults - added

The following medicines have been added/updated:

Botulinum Toxin Type A for cosmetic procedures - updated entry with resources

Sacubitril Valsartan for treating symptomatic chronic heart failure with reduced ejection fraction (NICE TA388) - updated entry with supporting information

Sodium Zirconium Cyclosilicate for treating hyperkalaemia (NICE TA599) - updated entry following NICE TA update

The following Items will be updated and added to the website following the next Strategic Commissioning Committee (SCC) Meeting:

Solriamfetol - Treating excessive daytime sleepiness caused by narcolepsy (NICE TA758)